3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Burkitt Lymphoma
9
Leukemia
6
Recurrence
4
Lymphoma
4
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Plasma Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Hodgkin Disease
2
Down Syndrome
2
Breast Neoplasms
2
Vomiting
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Smoldering Multiple Myeloma
1
Nausea
1
Malignant Neoplasms of Male Genital Organs
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Inflammatory Breast Neoplasms
1
Hypersensitivity
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
vinflunine
1
pembrolizumab
1
enfortumab vedotin
1
cabozantinib
1
avelumab
1
Watchful Waiting
1
Vitamin B 12
1
Platinum
1
Pemetrexed
1
Paclitaxel
1
Observation
1
Morphine
1
Immunoglobulin G
1
Gemcitabine
1
Folic Acid
1
Docetaxel
1
Disulfides
1
Dexamethasone
1
Cystoscopy
1
Cisplatin
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ureteral Neoplasms
×
Calcium Dobesilate
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled